PACS Group is trading at $48.78, up +6.88% after its August 4, 2026 earnings report showed $1.43 billion in second-quarter revenue and higher full-year guidance.
- Management raised adjusted EBITDA guidance to $640 million–$660 million, while revenue exceeded estimates.
- The earnings call reinforced confidence in continued growth. Healthcare-sector strength is providing additional support, but the earnings and guidance update appears to be the primary catalyst.